Sleep Apnea Syndrome and Community Acquired Pneumonia
NEBULOSA
Prevalence of Sleep Apnea-hypopnea Syndrome in Patients With Community Acquired Pneumonia, Prospective and Comparative Case-control Study
1 other identifier
observational
123
1 country
1
Brief Summary
The association of sleep apnea-hypopnea syndrome (SAHS) with the infections of the lower airway has not been studied. The aspiration of secretions of the upper airway and the colonization by microorganisms is considered a main event in most of the cases of community acquired pneumonia (CAP) , and specially in the nosocomial pneumonia. The silent aspiration to the lower airway is a common phenomenon in normal subjects during the sleep and some studies has reported that the patients with SAHS present an increase of the risk to pharyngeal aspirations. In fact, the presence of nasal and bronchial inflammation in patients with SAHS is a recognized event. The patients with SAHS could have a risk increased to develop pneumonia due to predisposition to the pharyngeal microaspiration to lower airways during the sleep and other mechanical factors associated. The prevalence of SAHS in patients with CAP could be increased as regards the data published for the same Spanish population. The presence of an apnea-hypopnea index (AHI) could be a risk factor not only to to CAP but to to present a unfavorable clinical evolution in comparison to patients with CAP with a normal AHI. The aim of this study will establish a relation between SAHS and the pneumonia risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 18, 2010
CompletedFirst Posted
Study publicly available on registry
February 19, 2010
CompletedFebruary 19, 2010
February 1, 2006
2.7 years
February 18, 2010
February 18, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the prevalence of sleep anea-hypopnea syndrome in patients with community acquired pneumonia, defined by an apnea-hypopnea index more to 12 measured by respiratory polygraphy
2 years
Secondary Outcomes (2)
To evaluate if the apnea-hypopnea index is a factor risk to community acquired pneumonia
2 years
To evaluate if a high apnea-hypopnea index is observed in patients with community acquired pneumonia and if is maintained after the pneumonia resolution
2 years
Study Arms (2)
Control Group (B): Other Infections
Other infections admitted to the hospital
Community Acquired Pneumonia (Group A)
Patients admitted to hospital with Community Acquired Pneumonia defined by respiratory symptoms, fever and lung infiltrates
Interventions
Both groups will be studied with in-hospital respiratory polygraphy during the sleep. The group A will be studied with another respiratory polygraphy in the home one month after the resolution of CAP. Some questionnaires to measure the sleepiness (Epworth test), FOSQ test, in-home sleepiness questionnaire and symptoms questionary will be obtained in Group A and B
Eligibility Criteria
Patients admitted to hospital with the diagnosis of community acquired pneumonia, excluding nosocomial pneumonia compared to patients with other infections excluding respiratory infections, admitted to hospital, paired by age, sex and body mass index
You may qualify if:
- Hospital admission and Community acquired pneumonia
You may not qualify if:
- Nosocomial infections
- Low level of conscientiousness
- Neurological disease
- Impossibility to complete the questionnaires
- Group B
- Hospital admission and other infections different to respiratory infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sección de Neumología. Hospital Universitario San Juan de Alicante
Sant Joan d'Alacant, Alicante, 03550, Spain
Related Publications (1)
Chiner E, Llombart M, Valls J, Pastor E, Sancho-Chust JN, Andreu AL, Sanchez-de-la-Torre M, Barbe F. Association between Obstructive Sleep Apnea and Community-Acquired Pneumonia. PLoS One. 2016 Apr 6;11(4):e0152749. doi: 10.1371/journal.pone.0152749. eCollection 2016.
PMID: 27050437DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Eusebi Chiner, MD
Head of Pneumology Section
- PRINCIPAL INVESTIGATOR
Mónica Llombart, MD
Consultant
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 18, 2010
First Posted
February 19, 2010
Study Start
April 1, 2006
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
February 19, 2010
Record last verified: 2006-02